Senior Advisor 2 for Biological Therapeutics Development to act as External Oversight Committee (EOC) Subject Matter Expert (SME) Services.
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
OMAS STRATEGIC BUYING CENTER - PROFESSIONAL SERVICES
Contract Value
Not provided
Codes & Classification
Solicitation Number
7571PSQ00013
NAICS
541690 - Other Scientific and Technical Consulting Services
Classification Code
R499
Additional Details
The Department of Health and Human Services (HHS), through the Office of the Assistant Secretary for Financial Resources (ASFR) and the OMAS Strategic Buying Center – Professional Services, has issued a combined synopsis/solicitation (Solicitation Number: 7571PSQ00013) for the procurement of Senior Advisor 2 services as a Subject Matter Expert (SME) to support the NIH Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) drug discovery and development programs, specifically serving as an expert member of the BPN-Biologics External Oversight Committee (EOC). This requirement is set aside exclusively for small business concerns under NAICS code 541690 (Other Scientific and Technical Consulting Services), with a small business size standard of $19 million.
Purpose and Scope:
The primary objective of this procurement is to secure the services of a highly experienced, executive-level Senior Advisor with extensive expertise in drug discovery and development. The selected SME will provide critical oversight and guidance to the BPN-Biologics program, which is part of the NIH HEAL Initiative—a trans-agency effort aimed at accelerating scientific solutions to address the national opioid public health crisis. The SME will contribute to the External Oversight Committee, ensuring that the program’s drug discovery and development activities are conducted with scientific rigor and strategic direction.
Key Requirements and Deliverables:
Offerors must demonstrate the capability to provide expert-level consulting in biological therapeutics development, with a focus on drug discovery and development. The technical requirements emphasize personnel qualifications, requiring submission of resumes and letters of commitment for proposed key personnel. All key personnel must be employed by the offeror by the start of the contract period. A narrative must accompany resumes, detailing how the proposed personnel meet the evaluation criteria.
The anticipated level of effort is approximately 50 labor hours per year, with the possibility of reimbursement for up to $2,000 in annual travel expenses per consultant, subject to government approval. If additional staff are proposed, their roles and rationale must be clearly articulated, and any other direct costs (ODCs) must be justified and documented in the price template and narrative.
The contract will be awarded as a Fixed Price purchase order, with a base period of performance from November 13, 2026, to November 14, 2027, and two option years extending through November 14, 2029. The total contract duration, including options, will not exceed three years. The government reserves the right to make one award, multiple awards, or no awards.
Contracting Entity and Location:
The place of performance is Bethesda, Maryland. The contracting entity is the OMAS Strategic Buying Center – Professional Services, operating under the Department of Health and Human Services, Office of the Assistant Secretary for Financial Resources. The primary point of contact for this solicitation is Dave Romley ([email protected]), with secondary contact Michelle Cecilia ([email protected], 301-272-9118).
Procurement Type and Special Considerations:
This is a competitive procurement for commercial products or services, prepared in accordance with FAR Part 12. The acquisition is set aside for small businesses, and all offerors must be actively registered in the System for Award Management (SAM) at the time of quote submission. The solicitation incorporates numerous FAR and HHSAR provisions and clauses by reference, including requirements for information and communication technology accessibility, contractor personnel security, and key personnel management. Notably, salary rate limitations apply, prohibiting the use of NIH funds to pay direct annual salaries in excess of the Executive Schedule, Level II.
Technical and Business Evaluation:
Quotations will be evaluated based on technical capability, price, and past performance. Offerors must provide evidence of recent and relevant past performance, including details of similar projects, contract numbers, amounts, agency contacts, and narratives explaining relevance. Responses are limited to ten single-sided pages, excluding resumes, letters of commitment, representations and certifications, and the completed price template.
Submission Instructions:
All required materials must be submitted electronically by 12:00 PM Eastern Time on November 5, 2026, referencing solicitation number 7571PSQ00013. Questions regarding the solicitation must be submitted by October 29, 2026, at 12:00 PM EST. Offerors must include their company’s full name and address, Unique Entity ID (UEI), authorized contact information, Taxpayer Identification Number (TIN), and certification of business size.
Constant Elements:
Throughout the contract lifecycle, the place of performance will remain Bethesda, Maryland, and the requirement will consistently focus on providing expert oversight and guidance for the BPN-Biologics drug discovery and development programs. The contract will adhere to the fixed price structure, small business set-aside, and compliance with FAR and HHSAR provisions. Key personnel management and salary limitations will remain in effect, ensuring continuity and compliance.
For further details, including attachments and full solicitation text, interested parties should refer to the official notice at https://sam.gov/opp/ef37fc0b343041cc84a69768230f3552/view.
This opportunity is well-suited for small businesses with proven expertise in scientific and technical consulting for biological therapeutics, particularly those with experience supporting federal drug discovery and development initiatives. Contractors should carefully review the Statement of Work and evaluation criteria to ensure alignment with their capabilities and prepare comprehensive responses as outlined in the solicitation.
Documents9